Innovus Pharmaceuticals Inc Aktie OTC Bulletin Board
Aktien
US45778V1061
Pharmazeutika
Schlusskurs
Andere Börsenplätze
|
||
- USD | - |
Manager | Titel | Alter | Seit |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01.06.18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
% 1. Jan. | Kap. | |
---|---|---|
+51,82 % | 797 Mrd. | |
+40,45 % | 628 Mrd. | |
+16,95 % | 323 Mrd. | |
+9,49 % | 300 Mrd. | |
+17,25 % | 244 Mrd. | |
+0,41 % | 223 Mrd. | |
+10,22 % | 214 Mrd. | |
+5,30 % | 163 Mrd. | |
-6,29 % | 153 Mrd. |